logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Corticosteroid Epc

    Medications for Corticosteroid Epc

    FiltersReset Filters
    3 results

    • betamethasone dipropionate

      (Betamethasone dipropionate)
      Lupin Pharmaceuticals, Inc.
      Usage: Betamethasone dipropionate ointment USP (augmented) is a corticosteroid indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions in individuals aged 13 and older.

    • desonide

      (Desonide)
      Viona Pharmaceuticals Inc
      Usage: Desonide cream, 0.05% is a low potency corticosteroid indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions. It should not be used for more than two weeks unless directed by a physician.

    • fluocinonide

      (Fluocinonide)
      IPG PHARMACEUTICALS, INC.
      Usage: Fluocinonide cream USP, 0.1% is indicated for relieving inflammatory and pruritic symptoms of corticosteroid-responsive dermatoses in patients aged 12 and older. Treatment should not exceed 2 consecutive weeks or 60 g per week. It is not recommended for rosacea, perioral dermatitis, or use on the face, groin, or axillae.